Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL518474 | 0.84 | CYP3A4 (0.38) | CA12CA1CA2CA9TSHR | |
| SCHEMBL518216 | 0.82 | TSHR (0.31) | TSHR | |
| SCHEMBL518053 | 0.82 | POLB (0.34) | POLBNPSR1TSHRGAA | |
| SCHEMBL517780 | 0.80 | EGFR (0.34) | TSHR | |
| SCHEMBL518217 | 0.77 | POLB (0.44) | POLBNPSR1KCNH2TSHRGAA | |
| SCHEMBL518054 | 0.71 | POLB (0.38) | POLBNPSR1CA12CA1CA2 | |
| SCHEMBL517781 | 0.71 | POLB (0.38) | POLBNPSR1CA12CA1CA2 | |
| SCHEMBL3206782 | 0.71 | CDC14B (0.36) | — | |
| SCHEMBL517591 | 0.69 | GAA (0.34) | GAA | |
| SCHEMBL517977 | 0.67 | CYP3A4 (0.33) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120029224-A1 | PROCESS FOR THE PREPARATION OF HALOGENATED ARYL PHOSPHONATES | BROMINE COMPOUNDS LTD. (IL) | 2012-02-02 | — | — | US | claimed |
| WO-2010046898-A1 | A PROCESS FOR THE PREPARATION OF HALOGENATED ARYL PHOSPHONATES | BROMINE COMPOUNDS LTD. (IL) | 2010-04-29 | — | — | WO | claimed |
| US-8405069-B2 | Printable thin-film transistors with high dielectric constant gate insulators and methods for producing same | GEORGIA TECH RESEARCH CORPORATION (US) | 2013-03-26 | — | — | US | disclosed |
| US-20120029224-A1 | PROCESS FOR THE PREPARATION OF HALOGENATED ARYL PHOSPHONATES | BROMINE COMPOUNDS LTD. (IL) | 2012-02-02 | — | — | US | disclosed |
| US-7960456-B2 | Halogenated phosphonates, processes for their preparation and their use as flame retardants | BROMINE COMPOUNDS LTD. (IL) | 2011-06-14 | — | — | US | disclosed |
| US-20100305252-A1 | Halogenated Phosphonates, Processes for Their Preparation and Their Use as Flame Retardants | BROMINE COMPOUNDS LTD. (IL) | 2010-12-02 | — | — | US | disclosed |
| WO-2010046898-A1 | A PROCESS FOR THE PREPARATION OF HALOGENATED ARYL PHOSPHONATES | BROMINE COMPOUNDS LTD. (IL) | 2010-04-29 | — | — | WO | disclosed |
| US-20100051917-A1 | PRINTABLE THIN-FILM TRANSISTORS WITH HIGH DIELECTRIC CONSTANT GATE INSULATORS AND METHODS FOR PRODUCING SAME | NATIONAL SCIENCE FOUNDATION | 2010-03-04 | — | — | US | disclosed |
| US-20100027192-A1 | COATED METAL OXIDE NANOPARTICLES AND METHODS FOR PRODUCING SAME | GEORGIA TECH RESEARCH CORPORATION | 2010-02-04 | — | — | US | disclosed |
| WO-2008060534-A1 | PRINTABLE THIN-FILM TRANSISTORS WITH HIGH DIELECTRIC CONSTANT GATE INSULATORS AND METHODS FOR PRODUCING SAME | GEORGIA TECH RESEARCH CORPORATION (US) | 2008-05-22 | — | — | WO | disclosed |
| EP-1888311-A2 | COATED METAL OXIDE NANOPARTICLES AND METHODS FOR PRODUCING SAME | GEORGIA TECH RESEARCH CORPORATION (US) | 2008-02-20 | — | — | EP | disclosed |
| WO-2006124670-A2 | COATED METAL OXIDE NANOPARTICLES AND METHODS FOR PRODUCING SAME | GEORGIA TECH RESEARCH CORPORATION (US) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305252-A1 | Halogenated Phosphonates, Processes for Their Preparation and Their Use as Flame Retardants | POLL, PFAS, POLN | POLB 6/4885NPSR1 3002/4885KCNH2 1142/4885 |
| US-20100027192-A1 | COATED METAL OXIDE NANOPARTICLES AND METHODS FOR PRODUCING SAME | NCL, PNN, NCDN | POLB 3047/4885NPSR1 828/4885KCNH2 1419/4885 |
| US-20120029224-A1 | PROCESS FOR THE PREPARATION OF HALOGENATED ARYL PHOSPHONATES | PIK3CA, PIP5K1B, PIP5K1C | POLB 1353/4885NPSR1 3576/4885KCNH2 1004/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.